111 related articles for article (PubMed ID: 37991523)
1. Perinatal HIV infection is associated with deficits in muscle function in children and adolescents in Zimbabwe.
Gregson CL; Rehman AM; Rukuni R; Mukwasi-Kahari C; Madanhire T; Kowo-Nyakoko F; Breasail MÓ; Jeena L; Mchugh G; Filteau S; Chipanga J; Simms V; Mujuru H; Ward KA; Ferrand RA
AIDS; 2024 May; 38(6):853-863. PubMed ID: 37991523
[TBL] [Abstract][Full Text] [Related]
2. Older age at initiation of antiretroviral therapy predicts low bone mineral density in children with perinatally-infected HIV in Zimbabwe.
Gregson CL; Hartley A; Majonga E; McHugh G; Crabtree N; Rukuni R; Bandason T; Mukwasi-Kahari C; Ward KA; Mujuru H; Ferrand RA
Bone; 2019 Aug; 125():96-102. PubMed ID: 31082498
[TBL] [Abstract][Full Text] [Related]
3. Effect of HIV infection on growth and bone density in peripubertal children in the era of antiretroviral therapy: a cross-sectional study in Zimbabwe.
Rukuni R; Rehman AM; Mukwasi-Kahari C; Madanhire T; Kowo-Nyakoko F; McHugh G; Filteau S; Chipanga J; Simms V; Mujuru H; Ward KA; Ferrand RA; Gregson CL
Lancet Child Adolesc Health; 2021 Aug; 5(8):569-581. PubMed ID: 34139202
[TBL] [Abstract][Full Text] [Related]
4. The IMpact of Vertical HIV infection on child and Adolescent SKeletal development in Harare, Zimbabwe (IMVASK Study): a protocol for a prospective cohort study.
Rukuni R; Gregson C; Kahari C; Kowo F; McHugh G; Munyati S; Mujuru H; Ward K; Filteau S; Rehman AM; Ferrand R
BMJ Open; 2020 Feb; 10(2):e031792. PubMed ID: 32041852
[TBL] [Abstract][Full Text] [Related]
5. Impaired Bone Architecture in Peripubertal Children With HIV, Despite Treatment With Antiretroviral Therapy: A Cross-Sectional Study From Zimbabwe.
Mukwasi-Kahari C; Rehman AM; Ó Breasail M; Rukuni R; Madanhire T; Chipanga J; Stranix-Chibanda L; Micklesfield LK; Ferrand RA; Ward KA; Gregson CL
J Bone Miner Res; 2023 Feb; 38(2):248-260. PubMed ID: 36426511
[TBL] [Abstract][Full Text] [Related]
6. Proximal renal tubular function in HIV-infected children on tenofovir disoproxil fumarate for treatment of HIV infection at two tertiary hospitals in Harare, Zimbabwe.
Mashingaidze-Mano R; Bwakura-Dangarembizi MF; Maponga CC; Morse GD; Monera-Penduka TG; Mtisi TJ; Mudzviti T; Mujuru HA
PLoS One; 2020; 15(7):e0235759. PubMed ID: 32634168
[TBL] [Abstract][Full Text] [Related]
7. Impact of tenofovir disoproxil fumarate on bone metabolism and bone mass among perinatally HIV-infected Asian adolescents.
Sudjaritruk T; Bunupuradah T; Aurpibul L; Kosalaraksa P; Kurniati N; Sophonphan J; Ananworanich J; Puthanakit T;
Antivir Ther; 2017; 22(6):471-479. PubMed ID: 27786155
[TBL] [Abstract][Full Text] [Related]
8. Fracture prevalence and its association with bone density among children living with HIV in Zimbabwe.
Rukuni R; Simms V; Rehman AM; Mukwasi-Kahari C; Mujuru H; Ferrand RA; Gregson CL
AIDS; 2023 Apr; 37(5):759-767. PubMed ID: 36728418
[TBL] [Abstract][Full Text] [Related]
9. Growth Profiles of Children and Adolescents Living with and without Perinatal HIV Infection in Southern Africa: A Secondary Analysis of Cohort Data.
Rehman AM; Sekitoleko I; Rukuni R; Webb EL; McHugh G; Bandason T; Moyo B; Ngwira LG; Mukwasi-Kahari C; Gregson CL; Simms V; Filteau S; Ferrand RA
Nutrients; 2023 Oct; 15(21):. PubMed ID: 37960240
[TBL] [Abstract][Full Text] [Related]
10. Muscle mass indicators as fat-free mass and lean soft tissue mass are associated with handgrip strength in HIV-diagnosed children and adolescents.
Martins PC; Souza Alves Junior CA; Augustemak de Lima LR; Petroski EL; Santos Silva DA
J Bodyw Mov Ther; 2022 Apr; 30():76-81. PubMed ID: 35500982
[TBL] [Abstract][Full Text] [Related]
11. Intramuscular depot medroxyprogesterone acetate accentuates bone loss associated with tenofovir disoproxil fumarate-containing antiretroviral therapy initiation in young women living with HIV (the BONE: CARE study): a prospective cohort study in Uganda.
Kiweewa Matovu F; Kiwanuka N; Nabwana M; Scholes D; Musoke P; Glenn Fowler M; Beksinska ME; Pettifor JM; Brown TT;
Lancet Glob Health; 2022 May; 10(5):e694-e704. PubMed ID: 35427526
[TBL] [Abstract][Full Text] [Related]
12. Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy: impact on bone mineral density in HIV-infected children.
Gafni RI; Hazra R; Reynolds JC; Maldarelli F; Tullio AN; DeCarlo E; Worrell CJ; Flaherty JF; Yale K; Kearney BP; Zeichner SL
Pediatrics; 2006 Sep; 118(3):e711-8. PubMed ID: 16923923
[TBL] [Abstract][Full Text] [Related]
13. Effect of different antiretroviral therapy on muscle mass, bone mineral density, and trabecular bone score in Chinese HIV-infected males.
Zhang Z; Lin Q; Xu Y; Guan W; Song X; Li Y; Zhang Y; Li T; Yu W
Arch Osteoporos; 2023 Apr; 18(1):48. PubMed ID: 37041320
[TBL] [Abstract][Full Text] [Related]
14. Zoledronic acid is superior to tenofovir disoproxil fumarate-switching for low bone mineral density in adults with HIV.
Hoy JF; Richardson R; Ebeling PR; Rojas J; Pocock N; Kerr SJ; Martinez E; Carr A;
AIDS; 2018 Sep; 32(14):1967-1975. PubMed ID: 29927785
[TBL] [Abstract][Full Text] [Related]
15. Total body and spinal bone mineral density across Tanner stage in perinatally HIV-infected and uninfected children and youth in PACTG 1045.
Jacobson DL; Lindsey JC; Gordon CM; Moye J; Hardin DS; Mulligan K; Aldrovandi GM;
AIDS; 2010 Mar; 24(5):687-96. PubMed ID: 20168204
[TBL] [Abstract][Full Text] [Related]
16. Adverse bone health and abnormal bone turnover among perinatally HIV-infected Asian adolescents with virological suppression.
Sudjaritruk T; Bunupuradah T; Aurpibul L; Kosalaraksa P; Kurniati N; Prasitsuebsai W; Sophonphan J; Sohn AH; Ananworanich J; Puthanakit T;
HIV Med; 2017 Apr; 18(4):235-244. PubMed ID: 27477214
[TBL] [Abstract][Full Text] [Related]
17. Bone Density, Microarchitecture, and Tissue Quality After Long-Term Treatment With Tenofovir/Emtricitabine or Abacavir/Lamivudine.
Güerri-Fernández R; Molina-Morant D; Villar-García J; Herrera S; González-Mena A; Guelar A; Trenchs-Rodríguez M; Díez-Pérez A; Knobel H
J Acquir Immune Defic Syndr; 2017 Jul; 75(3):322-327. PubMed ID: 28418990
[TBL] [Abstract][Full Text] [Related]
18. Body muscle gain and markers of cardiovascular disease susceptibility in young adulthood: A cohort study.
Bell JA; Wade KH; O'Keeffe LM; Carslake D; Vincent EE; Holmes MV; Timpson NJ; Davey Smith G
PLoS Med; 2021 Sep; 18(9):e1003751. PubMed ID: 34499663
[TBL] [Abstract][Full Text] [Related]
19. Bone measures in HIV-1 infected children and adolescents: disparity between quantitative computed tomography and dual-energy X-ray absorptiometry measurements.
Pitukcheewanont P; Safani D; Church J; Gilsanz V
Osteoporos Int; 2005 Nov; 16(11):1393-6. PubMed ID: 15702261
[TBL] [Abstract][Full Text] [Related]
20. Bone mineral density at the hip and its relation to fat mass and lean mass in adolescents: the Tromsø Study, Fit Futures.
Winther A; Jørgensen L; Ahmed LA; Christoffersen T; Furberg AS; Grimnes G; Jorde R; Nilsen OA; Dennison E; Emaus N
BMC Musculoskelet Disord; 2018 Jan; 19(1):21. PubMed ID: 29351755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
